Real-world experience with Temozolomide & Sativex in patients with recurrent High Grade Gliomas

BACKGROUND: Glioblastoma (GBM) is the most common malignant brain tumour in adults with a median survival from progression of 8 months. A recent phase 1 study of temozolomide (TMZ) and 1:1 CBD:THC (Sativex) offers evidence of efficacy in patients with recurrent GBM (NCT01812603). METHODS: All patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Shahabi, Lillie, Le Calvez, Kerlann, Dadhania, Seema, Blake, Catherine, Wang, James, Ingle, Manasi, Anichini, Giulio, Peterson, David, Nandi, Dipankar, Camp, Sophie, Saleem, Waqar, Falconer, Alison, O’Neill, Kevin, Williams, Matt
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6789945/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz167.057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados